AMBER KELLER: Open Payments
NPI 1164779997 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$36,300 in 170 payments from 14 companies in 2025. Trend: 2023 $1,324 · 2024 $25,820 · 2025 $36,300
Speaker / faculty: $28,350Travel & lodging: $5,490Food & beverage: $2,343Education: $117
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 62 | $34,857 |
| ABBVIE INC. | 25 | $281 |
| UCB, Inc. | 16 | $250 |
| Regeneron Healthcare Solutions, Inc. | 15 | $248 |
| Galderma Laboratories, L.P. | 24 | $184 |
| Amgen Inc. | 2 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| GENZYME CORPORATION | 4 | $73 |
| Organon LLC | 8 | $69 |
| Lilly USA, LLC | 3 | $53 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, OTEZLA, RINVOQ, TALTZ.
Industry payments across NC — which companies pay providers there.
